580 related articles for article (PubMed ID: 11400152)
21. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
[TBL] [Abstract][Full Text] [Related]
23. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis.
Flannelly J; Chambers MG; Dudhia J; Hembry RM; Murphy G; Mason RM; Bayliss MT
Osteoarthritis Cartilage; 2002 Sep; 10(9):722-33. PubMed ID: 12202125
[TBL] [Abstract][Full Text] [Related]
24. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
[TBL] [Abstract][Full Text] [Related]
25. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
26. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
27. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis.
Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Hung YC; Ueki M
Gynecol Endocrinol; 2002 Oct; 16(5):391-402. PubMed ID: 12587534
[TBL] [Abstract][Full Text] [Related]
28. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
29. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
[TBL] [Abstract][Full Text] [Related]
30. An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA
Vet J; 2009 Apr; 180(1):88-94. PubMed ID: 18295518
[TBL] [Abstract][Full Text] [Related]
31. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
32. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
34. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
[TBL] [Abstract][Full Text] [Related]
35. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
[TBL] [Abstract][Full Text] [Related]
36. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
37. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
38. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology.
Polette M; Clavel C; Cockett M; Girod de Bentzmann S; Murphy G; Birembaut P
Invasion Metastasis; 1993; 13(1):31-7. PubMed ID: 8407209
[TBL] [Abstract][Full Text] [Related]
39. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
Zhou J; Windsor LJ
J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
[TBL] [Abstract][Full Text] [Related]
40. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
